Detalles de la búsqueda
1.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
N Engl J Med
; 384(19): 1800-1809, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979488
2.
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
Am J Respir Crit Care Med
; 208(1): 13-24, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015033
3.
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.
Clin Exp Allergy
; 53(4): 417-428, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36507576
4.
Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study.
Ann Allergy Asthma Immunol
; 131(3): 343-348.e2, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263380
5.
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
Ann Allergy Asthma Immunol
; 131(5): 587-597.e3, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619779
6.
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res
; 21(1): 279, 2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087119
7.
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Respir Res
; 21(1): 264, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050928
8.
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res
; 21(1): 266, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050934
9.
Reply to Lipworth and Chan.
Am J Respir Crit Care Med
; 208(2): 212-213, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279366
10.
Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma.
J Clin Pharmacol
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632826
11.
Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.
Int J Clin Pract
; 67(4): 307-16, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23638466
12.
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.
NEJM Evid
; 2(10): EVIDoa2300135, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320181
13.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Lancet Respir Med
; 10(7): 650-660, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364018
14.
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study.
J Asthma Allergy
; 14: 1-11, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33469316
15.
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study.
J Asthma Allergy
; 14: 91-99, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568920
16.
Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.
Diabetes Metab Res Rev
; 26(7): 540-9, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20824678
17.
Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma.
J Allergy Clin Immunol Pract
; 11(3): 943-945.e2, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375743
18.
A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families.
Eur J Hum Genet
; 15(9): 980-7, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17551518
19.
Pubertal timing is an independent predictor of central adiposity in young adult males: the Gothenburg osteoporosis and obesity determinants study.
Diabetes
; 55(11): 3047-52, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17065341
20.
Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD study.
J Bone Miner Res
; 21(5): 790-5, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16734395